Coeptis Therapeutics (COEP) Stock Price
$13.88 0%
to add to portfolio
AI Score
-
Alternative
5 -
Fundamental
2 -
Technical
7
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.
Sign up to get access to more historical data and insights on Coeptis Therapeutics, AI stock picks, stock alerts and much more.
COEP AI Stock Analysis
AI stock analysis for COEP is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Coeptis Therapeutics (COEP) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Coeptis Therapeutics (COEP) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Coeptis Therapeutics (COEP), currently trading at $13.88, will... Sign up to access price prediction.
About COEP
-
Coeptis Therapeutics, Inc.
-
Symbol
COEP
-
Market
PNK
-
Industry
Biotechnology
-
Market Cap
48.8M
Similar Stocks
No similar companies found.
News
COEP Alternative Data
Web Traffic
Coeptis Therapeutics receives an estimated 2025 monthly visitors to coeptistx.com.
-
Web Traffic
2025
-
Change from Previous Month
39.9%
-
3 Month Change
59.4%
-
YoY Change
59.4%
Twitter Followers
Coeptis Therapeutics has 717 Twitter Followers on its main Twitter (also known as X) account, which is down by -18.1% over the last month.
-
Twitter Followers
717
-
Daily Change
0.7%
-
1 Month Change
18.1%
-
3 Month Change
30.2%
-
YoY Change
30.2%
Job Postings
Coeptis Therapeutics currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
LinkedIn Employees
According to LinkedIn, Coeptis Therapeutics has 5 employees.
-
LinkedIn Employees
5
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
Reddit Mentions
Coeptis Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
100%
LinkedIn Followers
2,097 are following Coeptis Therapeutics on LinkedIn.
-
LinkedIn Followers
2097
-
1 Month Change
0%
-
3 Month Change
0%
News Mentions
Coeptis Therapeutics was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
COEP Financials
COEP Key Metrics
-
Total Revenue
$1.9M
-
Net Income
-$1.9M
-
Earnings per Share
$4.09
-
Free cash flow
-$1.4M
-
EBITDA
-$4.5M
-
EBITDA Ratio
-2.41703
-
Total Assets
$8.9M
COEP 2-year Revenue & Income
COEP 2-year Free Cash Flow
COEP Technicals
COEP SMA
COEP RSI
FAQ
What's the current price of Coeptis Therapeutics (COEP) Stock?
The price of an Coeptis Therapeutics (COEP) share is $13.88.
What's the market cap of Coeptis Therapeutics?
The current market cap of Coeptis Therapeutics is 48.8M.
What are some stocks similar to Coeptis Therapeutics (COEP) that investors often compare it to?
There are no similar stocks listed for comparison with Coeptis Therapeutics (COEP).
What is the forecast for Coeptis Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Coeptis Therapeutics' stock price to be around $13.54 in 2026. Starting from the current price of $13.88, this represents a 2.5% change in price, indicating a neutral outlook for the stock.
How to buy Coeptis Therapeutics (COEP) Stock?
Coeptis Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Coeptis Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.